支气管哮喘治疗药物的研究进展  

Research Progress on Drugs for the Treatment of Bronchial Asthma

作　　者：宫裕娜 冯传杰[2] 

机构地区：[1]延安大学附属医院,陕西 延安 [2]延安大学附属医院急诊内科,陕西 延安

出　　处：《临床医学进展》2022年第4期3512-3519,共8页Advances in Clinical Medicine

摘　　要：支气管哮喘是全球常见的慢性呼吸道疾病。随着对哮喘有关生理、病理等机制的深入研究,用于治疗该疾病的药物不断被研发出来。现本文对治疗支气管哮喘药物进行概述,从药物种类、作用机制及治疗中出现的不良反应进行总结。Bronchial asthma is a common chronic respiratory disease worldwide. With the in-depth research on the physiological and pathological mechanisms related to asthma, a variety of different drugs have been developed for the treatment of asthma. This article now provides an overview of the drugs used in the treatment of bronchial asthma, summarizes the types of drugs, their mechanisms of action, and their adverse effects in treatment.

关 键 词：支气管哮喘 药物治疗 不良反应 

分 类 号：R562[医药卫生—呼吸系统]